Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Federal Reserve shifts to quarter-point rate rise but warns of more to come
    • ECB set to raise rates despite fall in eurozone inflation
    • ‘Hybrid identities’: why Germany is updating its citizenship rules
    • Italy to join forces with France in supplying air defences to Ukraine
    • Czech president-elect says west must accept China is ‘not friendly’
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Adani Enterprises calls off $2.4bn share sale
      • ‘Extreme leverage’? Adani’s debt-driven expansion under scrutiny
      • Adani sell-off tops $90bn as share sale fails to ease crisis
      • Gautam Adani defends ‘robust’ business as stock losses reach $100bn
      • How First Abu Dhabi Bank pursued Standard Chartered and ‘opened Pandora’s box’
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Adani Enterprises calls off $2.4bn share sale
      • Live news updates from February 1: Fed lifts rates 0.25 points, Eurozone inflation slows sharply
      • US stocks jump after Fed announces smaller rate rise
      • Shell profits more than double to record $40bn
      • Lebanon devalues official exchange rate by 90%
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
      Most Read
      • The return of the ‘British disease’
      • End the Fed ‘put’
      • Beware the great battery industry fallacy
      • Conservatives are forced to face the economic case for net zero
      • The corporate world is losing its grip on cyber risk
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Shoshana Zuboff: ‘Privacy has been extinguished. It is now a zombie’
      • A new generation refuses to keep quiet on age discrimination at work
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Alexa Chung on the unpolished appeal of Indie Sleaze
      • The secrets of the Mercedes-Benz Holy Halls
      • Why I’m only buying five new things in 2023
      • What a perilous flight from North Korea tells us about digital connections
      • Annie Morris and Idris Khan’s guide to West Sussex
    • HTSI
    1. Companies
    2. Health
    • Healthcare
    • Pharmaceuticals
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Health

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Wednesday, 1 February, 2023
      GSK PLC
      GSK bullish on 2023 as earnings surpass expectations

      UK drugmaker’s shingles vaccine boosts sales while demand for Covid-related products falls

    • Tuesday, 31 January, 2023
      AbbVie Inc
      Blockbuster AbbVie drug Humira to face competition in US for first time

      Amgen to launch ‘biosimilar’ version of medicine that has generated $200bn in sales since launch

    • Monday, 30 January, 2023
      National Health Service
      Doctors warn NHS must tackle staff shortages to fix emergency care crisis

      Sunak promises ‘largest and fastest-ever improvement’ in emergency waiting times in health service history

    • Monday, 30 January, 2023
      FT Globetrotter
      Running in London with the world’s oldest cross-country club

      Dating back to 1868, Thames Hare and Hounds is one of several running clubs in the capital with a long and colourful heritage. Our correspondent set off with them across Wimbledon Common

    • Monday, 30 January, 2023
      National Health Service
      Sunak’s NHS crisis plan to provide more ambulances, hospital beds and care at home

      Blueprint relies on ‘virtual’ wards and improved community care to alleviate bottlenecks

    • Sunday, 29 January, 2023
      News in-depthIllumina Inc
      Has Illumina taken the wrong path in its Grail quest?

      DNA sequencing expert’s investors question acquisition of cancer testing group that has also angered EU regulators

    • Sunday, 29 January, 2023
      Drugs research
      RQ Bio partners with AstraZeneca in Covid antibody fight

      UK biotech racing to keep antibody up to date with latest variants

    • Thursday, 26 January, 2023
      UK universities
      Lack of clinical academics threatens NHS research and teaching, say peers

      Shortage of doctors with university posts is putting health service on ‘dangerous precipice’

    • Tuesday, 24 January, 2023
      HTSI
      Plant-based, allergen-free – and totally delicious

      These aren’t just culinary alternatives, they’re the real gastronomic thing

    • Tuesday, 24 January, 2023
      Kate Bingham
      Britain is losing its chance to become a life sciences superpower

      Short-termism and suspicion in parts of government risk our valuable future in precision medicine

    • Tuesday, 24 January, 2023
      News in-depthDrug prices
      Big pharma groups rejoin battle with governments on drug prices

      Tight budgets and US reforms are ending a truce between the industry and health authorities

    • Monday, 23 January, 2023
      LexBayer AG
      Bayer: activist could revive fortunes of chemical group Premium content

      Ubben believes more could be done to isolate the liability to Roundup

    • Monday, 23 January, 2023
      FT Globetrotter
      The big soak: three rewarding, watery wellness experiences in Toronto

      Bliss out in a hammam, immerse yourself in an ice bath or go with the flow on a therapeutic-waters circuit

    • Monday, 23 January, 2023
      News in-depthCoronavirus treatment
      Rural China runs short of Covid drugs over lunar new year holiday

      Officials row with Pfizer over price as villages struggle to obtain antiviral medication

    • Sunday, 22 January, 2023
      Martin Wolf
      The dangers of magical thinking on health policy

      We must carefully consider how changes in the funding model might affect the healthcare system

    • Saturday, 21 January, 2023
      Miranda Green
      A cakeist manifesto: let us eat what we want

      The Food Standards Agency chair faces a wintry reception for her disapproval of unhealthy office treats

    • Friday, 20 January, 2023
      FT Weekend podcast30 min listen
      Surviving US healthcare. Plus: Prince Harry’s 'Spare'

      Claire Bushey explores the cost of US healthcare after her treatment for breast cancer. Then, Henry Mance reviews Prince Harry’s autobiography

    • Friday, 20 January, 2023
      HTSI
      The best products for hypersensitive skin

      Oils, serums, gels and balms to calm a compromised skin barrier

    • Thursday, 19 January, 2023
      The FT ViewThe editorial board
      The battle over European drug pricing

      UK and EU must balance health cost control with plans to grow life sciences

    • Wednesday, 18 January, 2023
      Working It
      How AI is combatting burnout

      Tech start-ups are building artificial intelligence-powered tools for employee wellbeing

    • Tuesday, 17 January, 2023
      InterviewJenny Harries
      Covid will ‘taunt us’ for years, says UK health security chief

      Future of pandemic less predictable than at the outset because of new variants, says Jenny Harries

    • Tuesday, 17 January, 2023
      Special Report
      Health at Work

      What the Britain’s Healthiest Workplace data tell us about the nation’s wellbeing, as tough economic times beckon. Also: counting the cost of rising long-term sickness on the economy; how organisations can tackle rising levels of exhaustion and retain staff; workspace designers are going all out on domesticity

    • Tuesday, 17 January, 2023
      Special ReportHealth at Work
      Help us find Britain’s healthiest workplace

      Enrol in FT/Vitality survey designed to identify best practices for improved wellbeing

    • Sunday, 15 January, 2023
      Coronavirus pandemic
      WHO calls on China to release more data on Covid outbreak

      Beijing reports almost 60,000 deaths in month since abandoning pandemic restrictions

    • Sunday, 15 January, 2023
      Travelista
      Five more feel-good destinations for 2023

      Beaches, baths, spinning and spas – from Norway to the Himalayas

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition
    • Top sections
    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports
    • FT recommends
    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In